Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/10459.1/56936
|
Título:
|
Factors predicting failure of endoscopic injection therapy in bleeding duodenal ulcer
|
|
Autor/a:
|
Brullet, Enric; Calvet, Xavier; Campo, Rafel; Rué i Monné, Montserrat; Catot, Llúcia; Donoso, Lluis
|
|
Notas:
|
Background: The aim of this study was to assess the factors that may cause
failure of endoscopic injection in patients bleeding from a duodenal ulcer.
Methods: One hundred twenty patients admitted for a bleeding duodenal ulcer
with active arterial hemorrhage or a nonbleeding visible vessel were included.
Results: Endoscopic injection was not feasible in 14 of 120 (11.6%) patients
because of inaccessibility or massive hemorrhage. The remaining 106 patients
underwent endoscopic therapy by injection of adrenaline and polidocanol. The
efficacy (achievement of definitive hemostasis) of endoscopy therapy was 83%
(88 of 106). Univariate analysis showed that failure of endoscopic injection was
related to age, presence of shock, ulcer size greater than 2 cm, and hemoglobin
level. Multivariate analysis showed that ulcer size greater than 2 cm
(p = 0.005) and the presence of shock (p = 0.03) were factors predictive of endoscopic
treatment failure. Failure to achieve hemostasis (p < 0.001) and poor
physical status measured by American Society of Anesthesiology classification
(p = 0.02) were significantly related to mortality.
Conclusions: Ulcer size and severity of hemorrhage are predictive of endoscopic
injection failure in patients bleeding from high-risk duodenal ulcers.
Survival is determined by clinical status and associated diseases. (Gastrointest
Endosc 1996;43:111-6.) |
|
Derechos:
|
(c) American Society for Gastrointestinal Endoscopy, 1996
info:eu-repo/semantics/restrictedAccess |
|
Tipo de documento:
|
article
publishedVersion |
|
Editor:
|
Elsevier
|
|
Compartir:
|
|
Documentos con el texto completo de este documento
Mostrar el registro completo del ítem
